Views & Analysis

The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.

Conducting successful commercial research in a primary care setting

https://pharmaphorum.com/patients/conducting-successful-commercial-research-in-a-primary-care-setting/

Patients/ Views & Analysis/ Views and analysis

A crisis of trust: How lack of sector confidence is threating patient centricity

Amanda Barrell Novartis, patient centricity, Scott Bradley, trust in pharma 0 Comment

People who trust pharma are more interested in using the industry’s services – making building confidence in the

A crisis of trust: How lack of sector confidence is threating patient centricity

https://pharmaphorum.com/patients/a-crisis-of-trust-how-lack-of-sector-confidence-is-threating-patient-centricity/

Market Access/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Saving lives doesn’t have to cost the Earth

mike.hammerton@pharmaphorum.com climate change, global warming, Jamie Phares, Janssen, Johnson & Johnson, pharma 0 Comment

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC),

Saving lives doesn’t have to cost the Earth

https://pharmaphorum.com/market-access-2/environmental-impact-saving-lives-doesnt-have-to-cost-earth/

American Telemedicine Association conference

Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

To increase clinical trial diversity, build trust in communities and use tech wisely

Jonah Comstock clinical trial diversity, decentralised clinical trials, marginalised communities, telehealth 0 Comment

After a long period of not much change, clinical trials are undergoing several massive shifts. At the American

To increase clinical trial diversity, build trust in communities and use tech wisely

https://pharmaphorum.com/patients/increase-clinical-trial-diversity-build-trust-in-communities-use-tech-wisely/

Patients/ Views & Analysis/ Views and analysis

Studying inequities throughout the pandemic

Jessica Hagen COVID-19, vaccines, WHO, world health organization 0 Comment

Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH)

Studying inequities throughout the pandemic

https://pharmaphorum.com/patients/studying-inequities-throughout-the-pandemic/

Patients/ Views & Analysis/ Views and analysis

Transparency, social change can help pharma regain the public’s trust

mike.hammerton@pharmaphorum.com impetus, Life Sciences, Natalie Yeadon, Transparency, trust 0 Comment

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine

Transparency, social change can help pharma regain the public’s trust

https://pharmaphorum.com/patients/transparency-social-change-can-help-pharma-regain-the-publics-trust/

Patients/ Views & Analysis/ Views and analysis

Engagement to partnership: The changing face of patient involvement

Amanda Barrell Iris Loew-Friedrich, patient engagement, UCB 0 Comment

The era of patient engagement is over. Instead, it’s time to move towards true partnership at every step

Engagement to partnership: The changing face of patient involvement

https://pharmaphorum.com/patients/engagement-to-partnership-changing-face-patient-involvement/

Patients/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Independent health comms agencies rebrand with emphasis on authenticity

Amanda Barrell healthcare communications, patient engagement, pharma 0 Comment

In a world of a million messages, should authenticity be the common thread tying all pharma communications and

Independent health comms agencies rebrand with emphasis on authenticity

https://pharmaphorum.com/views-analysis-patients/independent-health-comms-agencies-rebrand-with-emphasis-on-authenticity/

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Study finds unexpected prescription influencers in healthcare

Jessica Hagen Havas, MedSurvey, prescription 0 Comment

Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell

Study finds unexpected prescription influencers in healthcare

https://pharmaphorum.com/patients/study-finds-unexpected-prescription-influencers-in-healthcare/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login